A 62-year-old man presented with a 1-month history of right eye pain unresponsive to artificial tears and topical steroids. At presentation, bullous yellowish fluid collection was noted in the nasal conjunctiva. Corneal thinning and opacity were observed at the 3 o'clock position of the cornea. High-frequency radiowave ablation and biopsy were performed at the affected area. Conjunctival lymphangiectasia was confirmed by excisional biopsy. An improvement in the degree of corneal dellen and chemosis was evident 1 week after ablation. Use of a high-frequency radiowave electrosurgical device may be a simple and effective treatment option for symptomatic conjunctival lymphangiectasia.
Conjunctival lymphangiectasis is characterized by dilated lymphatic vessels of the bulbar conjunctiva and it occurs mainly in the interpalpebral area. [1] Although it usually resolves spontaneously without causing ocular symptoms, it can be associated with ocular symptoms such as irritation, dryness, epiphora, and pain. [2, 3] In such situations, more active treatment is necessary. Several therapeutic options, including topical steroid administration, surgical excision, and liquid nitrogen and subconjunctival bevacizumab injection, have been reported. [4] [5] [6] Han et al. [3] reported that high-frequency radiowave electrosurgery is a safe and effective modality for the treatment of symptomatic lymphangiectasis. However, in previous studies, lymphangiectasis was confirmed only by clinical diagnosis without histological confirmation by biopsy.
To our knowledge, however, corneal dellen in symptomatic lymphangiectasis has not been reported. Herein, we report a case of biopsy-proven conjunctival lymphangiectasia accompanied by corneal dellen, which was successfully treated using a high-frequency radiowave electrosurgical device.
Case Report
A 62-year-old man presented with a 1-month history of redness and ocular pain in the right eye. He was diagnosed with allergic conjunctivitis at a local clinic and was prescribed olopatadine twice per day and 0.5% loteprednol etabonate 4 times per day. Examination of the right eye revealed dilated lymphatic vessels and bullous conjunctival swelling, with a yellowish subconjunctival fluid in the nasal bulbar conjunctiva [ Fig. 1a ]. Focal corneal thinning and opacity were observed at the 3 o'clock position of the cornea. Anterior segment optical coherence tomography imaging revealed numerous dilated lymphatic vessels in the subconjunctival tissue [ Fig. 2 ]. A clinical diagnosis of corneal dellen secondary to conjunctival lymphangiectasia was suspected. Because the patient did not respond to conventional therapy, complained of severe pain due to dellen, we decided to undergo immediate treatment involving radiowave electro-ablation in the right eye. Before the ablation, a small piece of subconjunctival tissue was excised for confirmation of conjunctival lymphangiectasia. Conjunctival ablation was performed with reference to a protocol previously described by Han et al. [3] After instillation of 0.5% proparacaine (Alcaine, Alcon Laboratories, Fort Worth, TX), dilated lymphatic vessels and surrounding swollen conjunctiva were determined as target lesions. A fine-needle electrode from the 4.0-MHz radiowave system (Ellman Surgitron Dual Frequency RF; Ellman International, Inc., Hewlett, NY, USA) was inserted into the target area [ Fig. 3a and b]. One to 2 s of ablation caused a gradual change in the conjunctiva to a dusky white color (blanching) [ Fig. 3c ]. All ablations were performed at the lowest power setting of 1 (of 100) in the cutting mode. Histopathological examination revealed dilated lymphatic vessels and fluid collection, which is consistent with conjunctival lymphangiectasia [ Fig. 4 ].
One-week postoperatively, subconjunctival fluid accumulation was markedly decreased and corneal dellen was improved [ Fig. 1b ]. One-month postoperatively, the conjunctival injection had improved, with complete resolution of subconjunctival fluid accumulation and conjunctival lymphatic vessels [ Fig. 1c ]. The patient remained asymptomatic, with no signs of recurrence of lymphatic vessels at 4 months postoperatively, and no adverse effects were observed [ Fig. 1d ]. 
Discussion
Conjunctival lymphangiectasis may occur in association with previous ophthalmic surgery, radiotherapy, or other ocular diseases. [2, 7] It may disappear naturally without symptoms, however, when conjunctival edema is merged or enlarged, and symptoms such as irritation, dryness, and epiphora may occur. Surgical treatment is considered if there is no response to conservative treatment. [2] Dellen is the result of topical stromal dehydration caused by a reduced tear film spread over a focal corneal area. [8] [9] [10] Corneal dellen is characterized by corneal thinning and accompanied by an adjacent focal conjunctival or corneal elevation. Therefore, lymphaniectasia may cause corneal dellen. In general, lubrication and preservative-free artificial tear drops can be tried when corneal dellen is encountered. However, in this case, we decided to attempt surgical treatment because the patient showed no improvement on using topical therapy, and conjunctival chemosis due to lymphangiectasia persisted.
H i g h -f r e q u e n c y r a d i o wa ve e l e c t r o d e v i c e s u s e high-frequency (4 MHz) waves and have been applied to tissue for incision, dissection, hemostasis, and dehydration. These devices have been widely used in dermatology, general surgery, and plastic surgery. In ophthalmology, they are used for incision of the eyelid, treatment of distichiasis, conjunctivochalasis, superior limbic keratoconjunctivitis, and conjunctival cyst ablation. [11] [12] [13] [14] [15] The use of high-frequency radiowave electrodevices has been reported to be less time-consuming, cause less bleeding, and be less likely to cause complications because of less thermal injury to the surrounding tissues. [12, 15] When a high-frequency radiowave is applied to the subconjunctival tissue, it causes coagulation by local burns to tissues because of the friction of water molecules by the conversion of radiowaves into heat. [16] It is believed that lymphangiectasis is improved by inhibiting lymphatic fluid from entering the subconjunctival space as the dilated lymphatic wall and surrounding tissues collapse. [3] In this case, subconjunctival fluid decreased significantly at 7 days postoperatively, and at 1-month postoperatively, complete recovery was achieved. However, unlike previous studies, our case is more meaningful because conjunctival lymphangiectasia was confirmed on biopsy. In addition, in our case, corneal dellen accompanied lymphangiectasis. When a small piece of subconjunctival tissue is removed for biopsy, some subconjunctival fluid may leak, and the target area may consequently become ambiguous. However, as shown in Fig. 3 , in our case, the subconjunctival fluid did not leak through the simple drainage passage and the use of the preoperation anterior photograph allowed for ablation to be performed on the target area. We postulated that high-frequency electrosurgery is considered safer and more effective than surgical procedure because it has less effect on ocular surface irregularity and it can preserve more conjunctival tissues compared with surgical resection, which may contribute to delayed recovery of corneal dellen.
Conclusion
We confirmed conjunctival lymphangiectasis through biopsy and could effectively treat conjunctival lymphangiectasis and secondary corneal dellen in a short time period using a high-frequency radiowave electrosurgery device. Because high-frequency radiowave electrosurgery can preserve conjunctival tissue compared with surgical removal and has little effect on ocular surface irregularity, it appears to be a satisfactory treatment option that can be considered a preferential treatment before attempting an operative procedure in patients with conjunctival lymphangiectasis.
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